The Global Leader in Preclinical Ophthalmic Research
EyeCRO is the global leader in preclinical ophthalmic research specializing in studies of pharmacology/efficacy, PK/tox, and eyedrop formulation development. Efficacy models include dry eye, allergic conjunctivitis, laser-induced choroidal neovascularization, STZ-induced diabetes, ischemia/reperfusion, inherited retinal degenerations, optic nerve crush, light-induced retinal degeneration, geographic atrophy, retinal vascular leakage, Oxygen-induced retinopathy, corneal neovascularization, glaucoma, experimental autoimmune uveitis, and LC-MS quantification of A2E. Proprietary MiDROPS™ technology is also available to formulate small lipophilic molecules for topical instillation (eyedrop). This patented technology platform can produce stable and safe formulations that deliver large amounts of drug into the eye.